CL2014001172A1 - Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo - Google Patents

Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo

Info

Publication number
CL2014001172A1
CL2014001172A1 CL2014001172A CL2014001172A CL2014001172A1 CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1 CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1
Authority
CL
Chile
Prior art keywords
carrier
active agent
release
encapsulates
nucleus
Prior art date
Application number
CL2014001172A
Other languages
English (en)
Spanish (es)
Inventor
Patrick A C Gane
Patrick Schwarzentruber
Joachim Schoelkopf
Nicola Maiuta
Catherine Jean Ridgway
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014001172(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of CL2014001172A1 publication Critical patent/CL2014001172A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28Microcapsules or nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CL2014001172A 2011-11-10 2014-05-06 Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo CL2014001172A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
US201161559253P 2011-11-14 2011-11-14

Publications (1)

Publication Number Publication Date
CL2014001172A1 true CL2014001172A1 (es) 2014-09-12

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001172A CL2014001172A1 (es) 2011-11-10 2014-05-06 Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo

Country Status (25)

Country Link
US (1) US9579291B2 (enExample)
EP (1) EP2747752B1 (enExample)
KR (1) KR101612655B1 (enExample)
CN (1) CN103957893B (enExample)
AU (1) AU2012334082B2 (enExample)
BR (1) BR112014011310B1 (enExample)
CA (1) CA2851069C (enExample)
CL (1) CL2014001172A1 (enExample)
CO (1) CO6940430A2 (enExample)
DK (1) DK2747752T3 (enExample)
ES (1) ES2553091T3 (enExample)
IL (1) IL231959A0 (enExample)
IN (1) IN2014MN00843A (enExample)
MX (1) MX346884B (enExample)
MY (1) MY168425A (enExample)
PH (1) PH12014500750A1 (enExample)
PL (1) PL2747752T3 (enExample)
PT (1) PT2747752E (enExample)
RU (2) RU2018123688A (enExample)
SG (1) SG11201401350WA (enExample)
SI (1) SI2747752T1 (enExample)
SM (1) SMT201600010B (enExample)
TW (1) TWI625129B (enExample)
WO (1) WO2013068478A1 (enExample)
ZA (1) ZA201403611B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2719376T3 (en) 2012-10-12 2015-06-15 Omya Int Ag Gastroretentiv drug formulation and delivery systems and their method of preparation by the use of functional calcium carbonate
CA2899936A1 (en) * 2013-02-15 2014-08-21 Wellmark International Mineral feed-through formulation
TR201815327T4 (tr) 2015-06-10 2018-11-21 Omya Int Ag Anti-blokaj maddesi olarak yüzeyi tepkimeye girmiş kalsiyum karbonat kullanımı.
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
AU2017229125B2 (en) 2016-03-08 2021-07-29 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
CA3074843A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Long lasting cosmetic compositions
EP3694491A1 (en) 2017-10-10 2020-08-19 Capsugel Belgium NV Gelling multiparticulates
CN111356501A (zh) 2017-11-20 2020-06-30 生活实验公司 实现持久化妆品性能的属性
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
CN112041365A (zh) 2018-04-27 2020-12-04 生活实验公司 持久性化妆品组合物
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
WO2020091456A1 (ko) * 2018-10-31 2020-05-07 ㈜아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2025132417A1 (en) 2023-12-19 2025-06-26 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
EP0607467B1 (de) * 1992-12-01 1999-06-02 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
PL1974807T3 (pl) * 2007-03-21 2010-08-31 Omya Int Ag Sposób usuwania związków zaburzających procesy hormonalne
DE602007009124D1 (de) 2007-12-12 2010-10-21 Omya Development Ag Verfahren zur Herstellung von oberflächenreaktives Fällungskalziumkarbonat
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
EP2421507B1 (en) 2009-04-24 2019-01-23 Fertin Pharma A/S Chewing gum and particulate material for controlled release of active ingredients
EP2264109B1 (en) 2009-06-15 2012-01-25 Omya Development AG Process for preparing surface-reacted calcium carbonate and its use
PT2264108E (pt) 2009-06-15 2012-05-23 Omya Development Ag Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco

Also Published As

Publication number Publication date
RU2665382C1 (ru) 2018-08-29
SMT201600010B (it) 2016-02-25
BR112014011310A2 (pt) 2017-05-09
EP2747752A1 (en) 2014-07-02
IL231959A0 (en) 2014-05-28
WO2013068478A1 (en) 2013-05-16
NZ623515A (en) 2016-09-30
RU2018123688A3 (enExample) 2022-01-24
IN2014MN00843A (enExample) 2015-07-03
AU2012334082B2 (en) 2015-10-29
AU2012334082A1 (en) 2014-04-24
TWI625129B (zh) 2018-06-01
TW201328709A (zh) 2013-07-16
PT2747752E (pt) 2016-02-08
CO6940430A2 (es) 2014-05-09
BR112014011310B1 (pt) 2022-04-12
MX2014005466A (es) 2014-08-22
RU2018123688A (ru) 2019-03-07
US9579291B2 (en) 2017-02-28
PH12014500750A1 (en) 2014-05-12
CN103957893A (zh) 2014-07-30
EP2747752B1 (en) 2015-10-07
KR101612655B1 (ko) 2016-04-14
US20140248340A1 (en) 2014-09-04
CN103957893B (zh) 2017-08-15
MY168425A (en) 2018-11-09
ES2553091T3 (es) 2015-12-04
SI2747752T1 (sl) 2015-12-31
MX346884B (es) 2017-04-05
CA2851069C (en) 2016-05-31
KR20140091054A (ko) 2014-07-18
SG11201401350WA (en) 2014-05-29
ZA201403611B (en) 2015-07-29
PL2747752T3 (pl) 2016-04-29
CA2851069A1 (en) 2013-05-16
DK2747752T3 (en) 2016-01-18

Similar Documents

Publication Publication Date Title
CL2014001172A1 (es) Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo
CL2014002283A1 (es) Forma de dosificacion oral solida de liberacion inmediata que comprende particulas que comprenden un nucleo con un primer agente activo, un recubrimiento con un segundo agente activo sobre el y un material sensible al ph acido sobre dicho nucleo recubierto; proceso para prepararla; metodo de tratamiento; y uso para tratar dolor.
SG11201406514RA (en) Structures and methods for controlling fragrance release using encapsulated fragrance on container bodies
ZA201209424B (en) Method for delivering an active agent
BRPI0920383A2 (pt) método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia
BR112013018876A2 (pt) dispositivo de travamento, dispositivo de transferência com o mesmo, e método para controlar o dispositivo de travamento
BR112013009360A2 (pt) sistema e método para produção de ar líquido, armazenamento de energia e liberação de energia
SI3172964T1 (sl) Sestavki proti parazitom, ki obsegajo izoksazolinsko aktivno sredstvo, postopek in njihove uporabe
BRPI0912252A2 (pt) dispositivos oftálmicos para liberação controlada de agentes ativos.
PL2661798T3 (pl) Sposób komunikacji, komunikacyjny system i zawierający go system magazynowania energii
BR112013014203A2 (pt) peptídeo anfifílico bicéfalo, hidrogel e método para liberação de um agente bioativo
BR112012025375A2 (pt) compósito absorvente, artigo de cuidade pessoal absorvente e método para preparação de um artigo de cuidado pessoal absorvente
WO2012080833A3 (en) Controlled release dosage forms
BR112012031981A2 (pt) composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente
PL2770827T3 (pl) Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna
BR112013022411A2 (pt) artigo absorvente e método para preparar um artigo absorvente
BR112013014540A8 (pt) artigo absorvente e método para preparar o mesmo
PT2872187T (pt) Penso tendo a libertação controlada de agentes activos
LT2616329T (lt) Laivas su energijos tiekimo sistema ir energijos tiekimo sistemos valdymo būdas
ITTO20120461A1 (it) Agente per il controllo di ectoparassiti di animali.
BR112013009347A2 (pt) composição, uso de um composto, método para produzir uma camada de liberação adesiva, agente de liberação e película de liberação.
BR112014008527A2 (pt) núcleo absorvente
BR112013033914A2 (pt) agente para o controle de parasitas em animais e uso de um agente
BR112012022712A2 (pt) artigo abrasivo, e método para reformar um artigo abrasivo
ZA201304511B (en) An implant for the controlled release of pharmaceutically active agents